General Information


DRACP ID  DRACP03500

Peptide Name  

Sequence  FSPQMLQDIIEAATAIL

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03500

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C84H137N19O26S

Absent amino acids  CGHKNRVWY

Common amino acids  AI

Mass  214678

Pl  3.55

Basic residues  0

Acidic residues  2

Hydrophobic residues  9

Net charge  -2

Boman Index  278

Hydrophobicity  82.94

Aliphatic Index  132.35

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 20637182

Title  Functional analysis of an alpha-helical antimicrobial peptide derived from a novel mouse defensin-like gene

Doi Not available

Year  2010

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  5725

DRACP is developed by Dr.Zheng's team.